You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. FDA approves darolutamide for metastatic castration-sensitive prostate cancer
- 2. ESPN's Jay Harris Diagnosed With Prostate Cancer
- 3. It's my goal to live to 100 – and it's not just diet and exercise that will help me achieve it
- 4. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 5. Why is there such a generational divide in views on sex and gender in Britain? | Susanna Rustin
- 6. Private Astronaut Mission Includes Research to Open Space to Astronauts With Diabetes and Enable Early Cancer Detection
- 7. Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study
- 8. Prediction of metastatic risk of renal clear cell carcinoma based on CT radiomics analysis
- 9. Case Report: Liver and bladder metastasis in a patient with HR-positive, HER2-low breast cancer
- 10. Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Last updated at 18:34 GMT
Hot News Makers
Health/Pharma Companies
-
63892.19
-
46617.55
-
19703.17
-
9329.15
-
7666.18
-
6070.90
-
6036.01
-
5933.71
-
5126.88
-
4712.91
Drugs, Treatments, Trials
-
24274.60
-
9581.96
-
7945.56
-
7547.37
-
6561.48
-
5277.20
-
3707.72
-
3077.53
-
2952.63
-
2312.46
Last updated at 18:10 GMT
